Pathomechanisms of endogenously aged skin

Textbook of Aging Skin

Volumn , Issue , 2010, Pages 93-99

  Makrantonaki, Evgenia ^a   Zouboulis, Christos C ^b  

^a DESSAU MEDICAL CENTER   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77954423844     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-89656-2_9     Document Type: Chapter

References (74)

1. Diczfalusy E. The third age, the ThirdWorld and the third millennium. Contraception. 1996;53(1):1-7.
2. Oeppen J, Vaupel JW. Demography. Broken limits to life expectancy. Science. 2002;296(5570):1029-1031.
3. Aleksandrova S, Velkova A. Population ageing in the Balkan countries. Folia Med (Plovdiv). 2003;45(4):5-10.
4. Makrantonaki E, Zouboulis CC, William J. Cunliffe Scientific Awards. Characteristics and pathomechanisms of endogenously aged skin. Dermatology. 2007;214(4):352-360.
5. Hayflick L. The Limited in vitro lifetime of human diploid cell strains. Exp Cell Res. 1965;37:614-636.
6. Kosmadaki MG, Gilchrest BA. The role of telomeres in skin aging/photoaging. Micron. 2004;35(3):155-159.
7. Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279(5349):349-352.
8. Smith JR, Pereira-Smith OM. Replicative senescence: Implications for in vivo aging and tumor suppression. Science. 1996;273 (5271):63-67.
9. Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA. 1992;89(21):10114-10118.
10. Michikawa Y, Mazzucchelli F, Bresolin N, et al. Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science. 1999;286(5440):774-779.
11. Miquel J. An update on the oxygen stress-mitochondrial mutation theory of aging: Genetic and evolutionary implications. Exp Gerontol. 1998;33(1-2):113-126.
12. Benn PA. Specific chromosome aberrations in senescent fibroblast cell lines derived from human embryos. Am J Hum Genet. 1976;28 (5):465-473.
13. Ly DH, Lockhart DJ, Lerner RA, et al. Mitotic misregulation and human aging. Science. 2000;287(5462):2486-2492.
14. Gilchrest BA. In vitro assessment of keratinocyte aging. J Invest Dermatol. 1983;81(1 Suppl):184s-189s.
15. Cristofalo VJ, Pignolo RJ. Replicative senescence of human fibroblast-like cells in culture. Physiol Rev. 1993;73(3):617-638.
16. Gilchrest BA, Vrabel MA, Flynn E, et al. Selective cultivation of human melanocytes from newborn and adult epidermis. J Invest Dermatol. 1984;83(5):370-376.
17. Barja G. Free radicals and aging. Trends Neurosci. 2004;27 (10):595-600.
18. Kohen R. Skin antioxidants: Their role in aging and in oxidative stress-new approaches for their evaluation. Biomed Pharmacother. 1999;53 (4):181-192.
19. Sohal RS, Weindruch R. Oxidative stress, caloric restriction, and aging. Science. 1996;273(5271):59-63.
20. Hensley K, Floyd RA. Reactive oxygen species and protein oxidation in aging: A look back, a look ahead. Arch Biochem Biophys. 2002;397 (2):377-383.
21. Cuervo AM, Dice JF. How do intracellular proteolytic systems change with agé. Front Biosci. 1998;3d:25-43.
22. Lee CK, Klopp RG, Weindruch R, et al. Gene expression profile of aging and its retardation by caloric restriction. Science. 1999;285 (5432):1390-1393.
23. Kritchevsky D. Caloric restriction and experimental carcinogenesis. Hybrid Hybridomics. 2002;21(2):147-151.
24. Lu J, Xie L, Sylvester J, et al. Different gene expression of skin tissues between mice with weight controlled by either calorie restriction or physical exercise. Exp Biol Med (Maywood). 2007;232(4): 473-480.
25. Harley CB Telomere loss: Mitotic clock or genetic time bomb?Mutat Res. 1991;256(2-6):271-282.
26. Wu KJ, Grandori C, Amacker M, et al. Direct activation of TERT transcription by c-MYC. Nat Genet. 1999;21(2):220-224.
27. Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science. 1995;269(5228):1236-1241.
28. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266(5193):2011-2015.
29. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature. 1990;345(6274):458-460.
30. Hastie ND, Dempster M, Dunlop MG, et al. Telomere reduction in human colorectal carcinoma and with ageing. Nature. 1990;346 (6287):866-868.
31. Guarente L, Kenyon C. Genetic pathways that regulate ageing in model organisms. Nature. 2000;408(6809):255-262.
32. Jazwinski SM. The RAS genes: A homeostatic device in Saccharomyces cerevisiae longevity. Neurobiol Aging. 1999;20(5):471-478.
33. Johnson TE, Henderson S, Murakami S, et al. Longevity genes in the nematode Caenorhabditis elegans also mediate increased resistance to stress and prevent disease. J Inherit Metab Dis. 2002;25 (3):197-206.
34. Rogina B, Reenan RA, Nilsen SP, et al. Extended life-span conferred by cotransporter gene mutations in Drosophila. Science. 2000;290 (5499):2137-2140.
35. Tatar M, Kopelman A, Epstein D, et al. A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science. 2001;292(5514):107-110.
36. Arking R, Buck S, Hwangbo DS, et al. Metabolic alterations and shifts in energy allocations are corequisites for the expression of extended longevity genes in Drosophila. Ann N Y Acad Sci. 2002;959:251-262; discussion 463-255.
37. Kuro-o M, Matsumura Y, Aizawa H, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997;390(6655):45-51.
38. Yu CE, Oshima J, Fu YH, et al. Positional cloning of the Werner's syndrome gene. Science. 1996;272(5259):258-262.
39. Rattan SI. Aging, anti-aging, and hormesis. Mech Ageing Dev. 2004;125(4):285-289.
40. Partridge L, Gems D. A lethal side-effect.Nature. 2002;418(6901):921.
41. Gilchrest BA, Garmyn M, Yaar M. Aging and photoaging affect gene expression in cultured human keratinocytes. Arch Dermatol. 1994;130(1):82-86.
42. Yaar M, Eller MS, Bhawan J, et al. In vivo and in vitro SPRR1 gene expression in normal and malignant keratinocytes. Exp Cell Res. 1995;217(2):217-226.
43. Seshadri T, Campisi J. Repression of c-fos transcription and an altered genetic program in senescent human fibroblasts. Science. 1990;247(4939):205-209.
44. Hara E, Yamaguchi T, Nojima H, et al. Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. J Biol Chem. 1994;269 (3):2139-2145.
45. Simard M, Manthos H, Giaid A, et al. Ontogeny of growth hormone receptors in human tissues: An immunohistochemical study. J Clin Endocrinol Metab. 1996;81(8):3097-3102.
46. Noda A, Ning Y, Venable SF, et al. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res. 1994;211(1):90-98.
47. Jenkins G. Molecular mechanisms of skin ageing. Mech Ageing Dev. 2002;123(7):801-810.
48. Uitto J. Biochemistry of the elastic fibers in normal connective tissues and its alterations in diseases. J Invest Dermatol. 1979;72 (1):1-10.
49. Fisher GJ, Kang S, Varani J, et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol. 2002;138(11): 1462-1470.
50. Chung JH, Kang S, Varani J, et al. Decreased extracellularsignal- regulated kinase and increased stress-activated MAP kinase activities in aged human skin in vivo. J Invest Dermatol. 2000; 115(2):177-182.
51. Xia Z, Dickens M, Raingeaud J, et al. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 1995;270(5240): 1326-1331.
52. Verheij M, Bose R, Lin XH, et al. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature. 1996;380 (6569):75-79.
53. Zeng G, McCue HM, Mastrangelo L, et al. Endogenous TGF-beta activity is modified during cellular aging: Effects on metalloproteinase and TIMP-1 expression. Exp Cell Res. 1996;228(2):271-276.
54. Wick M, Burger C, Brusselbach S, et al. A novel member of human tissue inhibitor of metalloproteinases (TIMP) gene family is regulated during G1 progression, mitogenic stimulation, differentiation, and senescence. J Biol Chem. 1994;269(29):18953-18960.
55. Mori Y, Hatamochi A, Arakawa M, et al. Reduced expression of mRNA for transforming growth factor beta (TGF beta) and TGF beta receptors I and II and decreased TGF beta binding to the receptors in in vitro-aged fibroblasts. Arch Dermatol Res. 1998;290 (3):158-162.
56. Kyng KJ, May A, Kolvraa S, et al. Gene expression profiling in Werner syndrome closely resembles that of normal aging. Proc Natl Acad Sci USA. 2003;100(21):12259-12264.
57. Lener T, Moll PR, Rinnerthaler M, et al. Expression profiling of aging in the human skin. Exp Gerontol. 2006;41(4):387-397.
58. Wallace DC. Mitochondrial defects in neurodegenerative disease. Ment Retard Dev Disabil Res Rev. 2001;7(3):158-166.
59. Tatar M, Bartke A, Antebi A. The endocrine regulation of aging by insulin-like signals. Science. 2003;299(5611):1346-1351.
60. Conboy IM, Conboy MJ, Wagers AJ, et al. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature. 2005;433(7027):760- 764.
61. Makrantonaki E, Adjaye J, Herwig R, et al. Age-specific hormonal decline is accompanied by transcriptional changes in human sebocytes in vitro. Aging Cell. 2006;5(4):331-344.
62. Nesbit M, Nesbit HK, Bennett J, et al. Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes. Oncogene. 1999;18(47):6469-6476.
63. Laron Z. Effects of growth hormone and insulin-like growth factor 1 deficiency on ageing and longevity. Novartis Found Symp. 2002;242:125-137; discussion 137-142.
64. Carroll PV, Christ ER, Bengtsson BA, et al. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab. 1998;83(2):382-395.
65. Tomlinson JW, Holden N, Hills RK, et al. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet. 2001;357(9254):425-431.
66. Rudman D, Feller AG, Nagraj HS, et al. Effects of human growth hormone in men over 60 years old. N Engl J Med. 1990;323(1):1-6.
67. Riedl M, Kotzmann H, Luger A. Growth hormone in the elderly man. Wien Med Wochenschr. 2001;151(18-20):426-429.
68. Brincat MP. Hormone replacement therapy and the skin. Maturitas. 2000;35(2):107-117.
69. Fuchs KO, Solis O, Tapawan R, et al. The effects of an estrogen and glycolic acid cream on the facial skin of postmenopausal women: A randomised histologic study. Cutis. 2003;71(6):481-488.
70. Sator PG, Schmidt JB, Sator MO, et al. The influence of hormone replacement therapy on skin ageing: A pilot study. Maturitas. 2001;39(1):43-55.
71. Schmidt JB, Binder M, Demschik G, et al. Treatment of skin aging with topical estrogens. Int J Dermatol. 1996;35(9):669-674.
72. Affinito P, Palomba S, Sorrentino C, et al. Effects of postmenopausal hypoestrogenism on skin collagen. Maturitas. 1999;33(3): 239-247.
73. Makrantonaki E, Vogel K, et al. Interplay of IGF-I and 17betaestradiol at age-specific levels in human sebocytes and fibroblasts in vitro. Exp Gerontol. 2008;43(10):939-946.
74. Makrantonaki E, Zouboulis CC. Skin alterations and diseases in advanced age. Drug Discov Today Dis Mec. 2008;5(2):e153-e162.